145 related articles for article (PubMed ID: 30906657)
1. CD8
Jackaman C; Gardner JK; Tomay F; Spowart J; Crabb H; Dye DE; Fox S; Proksch S; Metharom P; Dhaliwal SS; Nelson DJ
Oncoimmunology; 2019; 8(4):e1564452. PubMed ID: 30906657
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8(+) T cells in vivo.
Jackaman C; Majewski D; Fox SA; Nowak AK; Nelson DJ
Cancer Immunol Immunother; 2012 Dec; 61(12):2343-56. PubMed ID: 22714286
[TBL] [Abstract][Full Text] [Related]
3. The STING agonist, DMXAA, reduces tumor vessels and enhances mesothelioma tumor antigen presentation yet blunts cytotoxic T cell function in a murine model.
Graham PT; Nowak AK; Cornwall SMJ; Larma I; Nelson DJ
Front Immunol; 2022; 13():969678. PubMed ID: 36466911
[TBL] [Abstract][Full Text] [Related]
4. In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes.
Nelson D; Bundell C; Robinson B
J Immunol; 2000 Dec; 165(11):6123-32. PubMed ID: 11086045
[TBL] [Abstract][Full Text] [Related]
5. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
[TBL] [Abstract][Full Text] [Related]
6. Two overlapping subdominant epitopes identified by DNA immunization induce protective CD8(+) T-cell populations with differing cytolytic activities.
Rodriguez F; Slifka MK; Harkins S; Whitton JL
J Virol; 2001 Aug; 75(16):7399-409. PubMed ID: 11462012
[TBL] [Abstract][Full Text] [Related]
7. Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon.
Rodriguez F; Harkins S; Slifka MK; Whitton JL
J Virol; 2002 May; 76(9):4251-9. PubMed ID: 11932390
[TBL] [Abstract][Full Text] [Related]
8. Macrophage Depletion in Elderly Mice Improves Response to Tumor Immunotherapy, Increases Anti-tumor T Cell Activity and Reduces Treatment-Induced Cachexia.
Duong L; Radley-Crabb HG; Gardner JK; Tomay F; Dye DE; Grounds MD; Pixley FJ; Nelson DJ; Jackaman C
Front Genet; 2018; 9():526. PubMed ID: 30459812
[TBL] [Abstract][Full Text] [Related]
9. Efficient priming of CD8+ memory T cells specific for a subdominant epitope following Sendai virus infection.
Cole GA; Hogg TL; Coppola MA; Woodland DL
J Immunol; 1997 May; 158(9):4301-9. PubMed ID: 9126992
[TBL] [Abstract][Full Text] [Related]
10. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
[TBL] [Abstract][Full Text] [Related]
11. Noncompetitive expansion of cytotoxic T lymphocytes specific for different antigens during bacterial infection.
Vijh S; Pilip IM; Pamer EG
Infect Immun; 1999 Mar; 67(3):1303-9. PubMed ID: 10024575
[TBL] [Abstract][Full Text] [Related]
12. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
[TBL] [Abstract][Full Text] [Related]
13. Immunization with dendritic cells breaks immunodominance in CTL responses against minor histocompatibility and synthetic peptide antigens.
Grufman P; Sandberg JK; Wolpert EZ; Kärre K
J Leukoc Biol; 1999 Aug; 66(2):268-71. PubMed ID: 10449165
[TBL] [Abstract][Full Text] [Related]
14. A novel CD8-independent high-avidity cytotoxic T-lymphocyte response directed against an epitope in the phosphoprotein of the paramyxovirus simian virus 5.
Gray PM; Parks GD; Alexander-Miller MA
J Virol; 2001 Nov; 75(21):10065-72. PubMed ID: 11581375
[TBL] [Abstract][Full Text] [Related]
15. Decline of influenza-specific CD8+ T cell repertoire in healthy geriatric donors.
Lee JB; Oelke M; Ramachandra L; Canaday DH; Schneck JP
Immun Ageing; 2011 Aug; 8():6. PubMed ID: 21846352
[TBL] [Abstract][Full Text] [Related]
16. Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation.
van der Most RG; Murali-Krishna K; Lanier JG; Wherry EJ; Puglielli MT; Blattman JN; Sette A; Ahmed R
Virology; 2003 Oct; 315(1):93-102. PubMed ID: 14592762
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccination as a tool to identify subdominant CD8 T cell epitopes.
Chen Y; Takimoto T; Liu L; Surman S; Woodland DL
Vaccine; 1999 Nov; 18(7-8):720-7. PubMed ID: 10547432
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection.
Lee S; Miller SA; Wright DW; Rock MT; Crowe JE
J Virol; 2007 Mar; 81(5):2349-58. PubMed ID: 17182672
[TBL] [Abstract][Full Text] [Related]
19. Mutating the anchor residues associated with MHC binding inhibits and deviates CD8+ T cell mediated protective immunity against malaria.
Dobaño C; McTague A; Sette A; Hoffman SL; Rogers WO; Doolan DL
Mol Immunol; 2007 Mar; 44(9):2235-48. PubMed ID: 17169429
[TBL] [Abstract][Full Text] [Related]
20. New epitopes in ovalbumin provide insights for cancer neoepitopes.
Karandikar SH; Sidney J; Sette A; Selby MJ; Korman AJ; Srivastava PK
JCI Insight; 2019 Mar; 5(8):. PubMed ID: 30869653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
